To Top

Community

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Contribution
Market Prediction

Global Autoinjectors Market to 2023 - High-Value Biologics Boosting Market Growth

PR-M11-18-NI-041
Clinical Trial Data

BD Announces Clinical Trial Data for the LUTONIX® 014 Drug-Coated Balloon Below-The-Knee IDE Trial

PR-M11-18-NI-041
Appointment

Thermo Fisher Scientific Elects New Director to Board

PR-M11-18-NI-038
Drug Discovery

Sosei Enters Collaboration to Combine Pioneering DNA Technologies With StaR® Technology to Accelerate New Drug Discovery

PR-M11-18-NI-039
Financial Results

Trovagene Announces Third Quarter 2018 Highlights and Financial Results

PR-M11-18-NI-037
Strategic Partnership

Sharp announces preferred partner agreement with Berkshire Sterile Manufacturing

PR-M11-18-NI-035
Vaccine

Enesi Pharma and Sementis Sign R&D Collaboration Focused on Needle-free Solid Dose Vaccines for Peanut Allergy and Chikungunya/Zika Infection

PR-M11-18-NI-034
Probiotics

Visiongain Report Researches Growth Opportunities Within the $59bn Global Probiotics Market

PR-M11-18-NI-033
Real World Data

Initial results from EMPRISE real-world evidence study show Jardiance® was associated with reduced risk for hospitalization for heart failure compared with DPP-4 inhibitors

PR-M11-18-NI-032
Macular Degeneration

Oxurion and Beta Therapeutics to Develop New Heparanase Inhibitors for Treatment of dry AMD

PR-M11-18-NI-031
Cannabis

Beleave Announces Seven-for-One Share Split

PR-M11-18-NI-027
Licensing Agreement

MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan

PR-M11-18-NI-026
Oncology

Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer

PR-M11-18-NI-029
Cell and Gene Therapy

REGENXBIO and Abeona Therapeutics Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector

PR-M11-18-NI-028
Cannabis

The Medical Cannabis Market is Set to Expand as North American Continues to Grow

PR-M11-18-NI-025
Respiratory

Gala Enrolls First Subjects in an Early Feasibility Study of RheOx™ for Chronic Bronchitis in the United States

PR-M11-18-NI-023
Clinical Trials

Lipocine Announces Completion of Enrollment in LPCN 1144 Liver Imaging Study in Subjects At-Risk for NASH

PR-M11-18-NI-022
Stem Cells

Cellect Receives Multiple Patent Grants

PR-M11-18-NI-021
Licensing Agreement

Grünenthal Acquires Global Rights for Qutenza®

PR-M11-18-NI-020
FDA Approval

AcelRx Announces FDA Approval of DSUVIA™

PR-M11-18-NI-017
Dermatology

Galderma Announces FDA Approval of Restylane® Lyft For Midface Injection via Cannula

PR-M11-18-NI-019
Celiac Disease

Amgen and Provention Bio Announce Co-Development Collaboration In Celiac Disease

PR-M11-18-NI-018
Immunotherapy

I-Mab and Genexine Announce China IND Approval for Innovative Immunotherapy

PR-M11-18-NI-014
FDA Approval

Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN™ (clobazam) Oral Film

PR-M11-18-NI-013
Financial Results

AbbVie Reports Third-Quarter 2018 Financial Results

PR-M11-18-NI-012
Market Prediction

Migraine Drugs Market Rising at Steady 3.5% During 2017 - 2025; Abortive Treatment Generates Maximum Revenue - TMR

PR-M11-18-NI-011
Genetic Testing

Invitae expands work with Alnylam Pharmaceuticals to provide access to genetic testing for primary hyperoxaluria

PR-M11-18-NI-010
Acquisition

Australis Finalizes Definitive Agreement to Acquire Rthm Technologies Inc.

PR-M11-18-NI-009
Patent

Perrigo Confirms Patent Challenge For Generic Version Of Kerydin®

PR-M11-18-NI-008
Market Intelligence

Global Specialty Pharmaceutical Partnering Terms and Agreements Report 2012-2018: Analysis by Headline Value, Upfront Payments, Milestone Payments and Royalties

PR-M11-18-NI-007
New Faciliy

Thermo Fisher Scientific Opens Newly Expanded Facility in Frederick, Md.

PR-M11-18-NI-004
Analytic Testing

Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins

PR-M11-18-NI-003
Raw Materials

Green Science Alliance Co., Ltd. Has Started Production of Chitin Nanofiber, Chitosan Nanofiber

PR-M11-18-NI-002
Cannabis

Beleave Penetrates European Cannabis Market through Strategic Partnership and Adds VP International Sales

PR-M11-18-NI-001
Licensing Agreement

Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd. to Develop and Commercialize TAVALISSE™ in Japan and other Asian Countries

PR-M11-18-NI-005
Blindness

Diabetes Medication May Protect Against a Common Cause of Blindness

PR-M10-18-NI-108
Crohn's

Salix And Alfasigma Will Initiate Late-Stage Program To Study Rifaximin In Patients With Postoperative Crohn's Disease

PR-M10-18-NI-106
Diabetes

ActoBio Therapeutics™ Doses First Patient in Phase Ib/IIa Clinical Study of AG019 for the Treatment of Type 1 Diabetes

PR-M10-18-NI-105
New Facility

Thermo Fisher Scientific Opens Newly Expanded Facility in Frederick, Md.

PR-M10-18-NI-103
Clinical Trials

RegeneRx Partner Updates on Clinical Trials

PR-M10-18-NI-102
Autism Spectrum Disorder

AMO Pharma Reports Positive Data from Investigator-Led TIDE Study of AMO-02 in Autism Spectrum Disorder

PR-M10-18-NI-101
Investment

Castle Creek Pharma Raises Funding to Repurpose Diacerein

PAO-M10-18-NI-030
Biosimilars

Herceptin Biosimilar Gets Positive Opinion in Europe

PAO-M10-18-NI-024
Financial Results

Perrigo To Release Third Quarter Calendar Year 2018 Financial Results On November 8, 2018

PR-M10-18-NI-097
Market Prediction

Global Interventional Cardiology Market to Reach $24.96 Billion by 2027

PR-M10-18-NI-098
Novel Therapy

Novel Combination Therapy Promotes Wound Healing

PR-M10-18-NI-096
Medical Device

FDA Grants Breakthrough Device Status for MediBeacon's Transdermal GFR Measurement System

PR-M10-18-NI-094
Rheumatology

Mallinckrodt Presents Data on H.P. Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2018 ACR/ARHP Annual Meeting

PR-M10-18-NI-092
3D Bioprinting

CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants

PR-M10-18-NI-095
Licensing Agreement

REGENXBIO Announces Exclusive Worldwide License with Ultragenyx for the Treatment of CDKL5 Deficiency Disorder Using NAV Vectors

PR-M10-18-NI-093
FDA Approval

FDA Approves Asthma Indication for Dupixent® (dupilumab)

PR-M10-18-NI-090
Market Prediction

Global Wound Care Market Report 2018-2024

PR-M10-18-NI-089
Patient Adherence

Medisafe Partners with Merck KGaA, Darmstadt, Germany to Improve Adherence for Patients with Cardiometabolic Disorders in Russia, Mexico and Brazil

PR-M10-18-NI-088
Investment

Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections

PR-M10-18-NI-087
Mergers

TaiRx, Inc. and BioHealth Innovation, Inc. Form TaiRx US to Develop and Commercialize Therapeutics and Precision Medicine Diagnostics

PR-M10-18-NI-086
Shareholder

Nxt-ID Issues Shareholder Update

PR-M10-18-NI-083
Market Prediction

Liquid Biopsy Market to Reach $3,805 Mn, Globally, by 2023 at 28.9% CAGR, Says Allied Market Research

PR-M10-18-NI-084
Clinical Trials

Reistone Biopharma, a New Chinese Biotech Company Ready to Initiate its Ulcerative Colitis Phase II Clinical Trial Globally

PR-M10-18-NI-076
FDA Approval

Allergan Bags Another Body Contouring Approval

PAO-M10-18-NI-023
FDA

Another Biosimilar Gets Nod from Independent FDA Panel

PAO-M10-18-NI-018
Expansion

Almac Grows in North Carolina

PAO-M10-18-NI-016
Biosimilars

Mylan and Biocon Announce Positive CHMP Opinion for Ogivri®, Biosimilar Trastuzumab

PR-M10-18-NI-071
Immunotherapy

Guardant Health Presents Data on Immunotherapy-related Biomarkers MSI and TMB in blood of advanced cancer patients

PR-M10-18-NI-075
Clinical Trials

Ward MM and Endocanna Health Announce Partnership Supporting Medicinal Cannabis Clinical Trials

PR-M10-18-NI-074
Novel Technologies

Eclipse MedCorp Acquires Transformative Technology in Regenerative Medicine

PR-M10-18-NI-067
Strategic Partnership

Cronos Group Inc. Partners with Technion Research & Development Foundation for Cannabinoid-Based Skin Care Treatments

PR-M10-18-NI-068
ADHD

Aevi Genomic Medicine Announces Completion of Enrollment for Part B of the ASCEND Trial

PR-M10-18-NI-066
Stem Cells

Cellect Announces Positive Clinical Results

PR-M10-18-NI-065
Funding

GHIT Fund Welcomes Ono Pharmaceutical Co., Ltd. as New Funding Partner

PR-M10-18-NI-059
Data

Therap's Dashboard Analytics Tool Offers Aggregate Health Care Data Insight for Improved Health Outcomes

PR-M10-18-NI-058
PR-M10-18-NI-060

New Study Examines How Pharmaceutical Industry is Embracing Digital Patient Engagement Programs

Digital Health
Investment

GSK Funds British Biotech Sitryx

PAO-M10-18-NI-011
Oncology

Targovax Reports Encouraging Disease-free Survival (DFS) Data From Tg01 Trial in Resected Pancreatic Cancer

PR-M10-18-NI-055
Clinical Trials

OncoSec Initiates KEYNOTE-890, a Phase 2 Clinical Trial of TAVO in Combination with Merck's KEYTRUDA®

PR-M10-18-NI-053
Microbiome

Microsoft Genomics Ventures into the Microbiome With Eagle Genomics

PR-M10-18-NI-052
Phase 3

Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX301

PR-M10-18-NI-054
Drug Availability

Clarivate Analytics Launches Cortellis CMC Intelligence to Expand Drug Availability in Low and Middle Income Countries

PR-M10-18-NI-051
Antibiotics

The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries

PR-M10-18-NI-048
FDA Approval

FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing

PR-M10-18-NI-047
Multiple Myeloma

Sutro's STRO-001 Receives U.S. FDA Orphan Drug Designation for Treatment of Multiple Myeloma

PR-M10-18-NI-049
Market Prediction

Wearable Injectors (On-Body and Off-Body injectors (Infusion Pump Devices)) Market - Global Forecast to 2023

PR-M10-18-NI-046
Biosimilars

U.S. Department of Veterans Affairs Signs Contract with Merck for its Remicade Biosimilar

PAO-M10-18-NI-010
Clinical Trials

New Clinical Trial Will Evaluate Biomarkers as Predictors of Treatment Response in IBD

PAO-M10-18-NI-009
3D Imaging

Tissue Analytics Launches 3D Wound Imaging for Smartphones

PR-M10-18-NI-045
Patent

Zynex Obtains U.S. Patent for Blood Volume Monitor

PR-M10-18-NI-044
Market Prediction

Global Proton Therapy Market & Forecast 2018-2024: Europe Will Significantly Drive the Global Proton Therapy Market Due to the Rising Number of Proton Therapy Centers

PR-M10-18-NI-043
RNA

Janssen Collaborates on RNA Therapy

PAO-M10-18-NI-008
Clinical Data

Theravance Biopharma and Mylan to Present New Data from Studies of YUPELRI™ (revefenacin) at the 2018 CHEST Annual Meeting

PR-M10-18-NI-038
Genomics

A Global Leader in Genomics Chooses ValGenesis VLMS to Manage its Validation Process

PR-M10-18-NI-037
Announcement

Atlas Genetics Announces Company Rebranding, Changes Name To Binx Health

PR-M10-18-NI-036
Digital Health

Myovant Sciences and Flo Health Partner to Develop Digital Tool to Screen Women for Heavy Menstrual Bleeding

PR-M10-18-NI-040
Partnership

WellCare Partners with agilon health to Form Value-Based Care Agreement

PR-M10-18-NI-039
FDA Approval

FDA Grants Coordination Pharmaceuticals IND Approval for CPI-100, a Novel Antitumor Nanomedicine

PR-M10-18-NI-031
FDA Approval

Bausch Health's BRYHALI™(halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults

PR-M10-18-NI-033
Market Prediction

Global Pediatric Vaccine Market 2015-2024: Technologic Advancements and Increase in Government and Non-Government Funding

PR-M10-18-NI-035
FDA Approval

FDA Approves Expanded Use of Gardasil 9 to Include Individuals 27 Through 45 years old

PR-M10-18-NI-032
Clinical Study

Yisheng Biopharma Announces Clearance from China FDA to Proceed with PIKA Rabies Vaccine Clinical Study

PR-M10-18-NI-028
Innovation

Shining a Light on Depression - How Infrared Light Can Treat Depression

PR-M10-18-NI-030
Announcement

WuXi AppTec Group and Mayo Clinic Receive 2018 MedTech Insight Award for Best Alliance

PR-M10-18-NI-029
Partnership

Stryker's Advanced Guidance Technologies Announces Partnerships with Synaptive Medical and Ziehm Imaging

PR-M10-18-NI-026
Finance

Regeneron to Report Third Quarter 2018 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2018

PR-M10-18-NI-027
Immunotherapy

Increasing Number of Cancer Cases to Fuel the Global Cancer Immunotherapy Market Growth

PR-M10-18-NI-025
Expansion

CRB Opens Second Office in Europe, Hires Bernd Müller

PR-M10-18-NI-022
Clinical Study

Allergan Launches Personalized Study Approach for Clinical Research Programs in Inflammatory Bowel Disease

PR-M10-18-NI-024
FDA

FDA Allows Marketing of First Self-Fitting Hearing Aid controlled by the User

PR-M10-18-NI-021